AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18682624
Drug: Phentolamine mesylate
RxNorm normalized name: Phentolamine Mesylate
DrugBank: Phentolamine (DB00692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phentolamine mesylate (PM) injection
Trial: 18682624
Drug: Control (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (sham injection)
Trial: 16425390
Drug: Cefotaxime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (1 g every 6 h for 5 days)
Trial: 16425390
Drug: Amikacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin (500 mg once daily for 5 days)
Trial: 10389550
Drug: Beclomethasone 168
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone 168 micrograms plus salmeterol 42 micrograms twice daily
Trial: 10389550
Drug: Beclomethasone 336
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone 336 micrograms twice daily
Trial: 1354949
Drug: Mizolastine (SL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine (SL 85.0324) 2 mg to 75 mg
Trial: 1354949
Drug: Mizolastine (SL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine (SL 85.0324) 10 mg
Trial: 1354949
Drug: Mizolastine (SL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizolastine (SL 85.0324) up to 75 mg
Trial: 6373217
Drug: Naftidrofuryl (Dusodril)
RxNorm normalized name: naftidrofuryl
DrugBank: Naftidrofuryl (DB13588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftidrofuryl (Dusodril) 600 mg orally
Trial: 28069480
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 μg)
Trial: 28069480
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 μg)
Trial: 24856464
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no cervical priming agent)
Trial: 24856464
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (oral, sublingual, vaginal)
Trial: 20832986
Drug: Buspirone (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (a serotonin-selective agonist) administered in a double-blind, randomized, placebo-controlled protocol.
Trial: 11039606
Drug: Methylprednisolone sodium
RxNorm normalized name: methylPREDNISolone sodium phosphate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone sodium succinate (MPSL: 10 mg/kg body weight)
Trial: 11039606
Drug: MPSL followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPSL followed by continuous infusion of urinary trypsin inhibitor (UTI) for 3 days
Trial: 11039606
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of MPSL
Trial: 11039606
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of UTI in early postoperative phase after MPSL
Trial: 11039606
Drug: Preoperative MPSL
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative MPSL followed by UTI infusion for only one hour
Trial: 2218733
Drug: Dinoprostone (Prepidil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone (Prepidil Gel) applied 6 hours before abortion
Trial: 2218733
Drug: Dinoprostone (Prepidil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone (Prepidil Gel) applied 4 hours before abortion
Trial: 2218733
Drug: Dinoprostone (Prepidil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone (Prepidil Gel)
Trial: 340949
Drug: Single 3-g
RxNorm normalized name: glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 3-g oral dose of amoxicillin
Trial: 340949
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (10 days of amoxicillin, 250 mg, four times per day)
Trial: 28864219
Drug: Regenerative endodontic
RxNorm normalized name: Regener-Eyes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regenerative endodontic treatment (RET)
Trial: 23503480
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg/day) for 12 months
Trial: 17014579
Drug: Phlebotomy therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebotomy therapy (removal of 300-500 mL of blood every 14 days until serum ferritin < 100 microg/L)
Trial: 17014579
Drug: Control (follow-up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (follow-up without phlebotomy therapy)
Trial: 2008865
Drug: Naltrexone (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (100-150 mg/d)
Trial: 6807439
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone 600 mg/m2 daily for three days
Trial: 6807439
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 3 mg/kg daily for three days
Trial: 30608050
Drug: Vaccine-plus-behavior-change (handwashing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine-plus-behavior-change (handwashing promotion and drinking water chlorination)
Trial: 30608050
Drug: Cholera-vaccine-only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholera-vaccine-only
Trial: 26886418
Drug: Pioglitazone (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (target dose, 45 mg daily)
Trial: 22148897
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate (1 or 2 g/day)
Trial: 17947609
Drug: AA/DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AA/DHA supplementation (10 gel caps containing 500 mg of AA and 1000 mg of DHA daily for 6 weeks)
Trial: 17947609
Drug: OA/LA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OA/LA supplementation (250 mg of linolenic acid and 125 mg of oleic acid daily for 6 weeks)
Trial: 15617993
Drug: Cisplatin (CP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CP) + Vinorelbine (VNR) 25 mg/m(2) on days 1 and 8 as an intravenous bolus plus CP 75 mg/m(2) on day 1 (regimen A)
Trial: 15617993
Drug: Cisplatin (CP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CP) + Gemcitabine (GEM) 1200 mg/m(2) on days 1 and 8 as an intravenous 30-min infusion plus CP 75 mg/m(2) on day 1 (regimen B)
Trial: 7798688
Drug: PRP polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP polysaccharide vaccine
Trial: 7798688
Drug: Hib conjugate
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hib conjugate PRP-D vaccine
Trial: 7798688
Drug: Hib conjugate
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hib conjugate HbOC vaccine
Trial: 7798688
Drug: No vaccine
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No vaccine (unimmunized)
Trial: 7798688
Drug: Conjugate vaccines
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugate vaccines
Trial: 7798688
Drug: PRP conjugate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP conjugate vaccines
Trial: 30396622
Drug: Yoga as
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yoga as an adjunct therapy
Trial: 27550184
Drug: Gongjin-dan (GJD)
RxNorm normalized name: PANAX GINSENG FRUIT 229 mg in 4 g ORAL PELLET [Korea Gongjin-Dan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gongjin-dan (GJD) administered twice daily
Trial: 24508316
Drug: Manual mobilization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual mobilization of the wrist (10 minutes, integrated into therapy twice a week for 6 weeks)
Trial: 24508316
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (therapy based on Dutch guidelines for stroke without manual mobilization)
Trial: 17170051
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg BIIL 284
Trial: 17170051
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg BIIL 284
Trial: 17170051
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg BIIL 284
Trial: 9794948
Drug: Early surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early surfactant treatment (100 mg/kg body weight bovine surfactant)
Trial: 9794948
Drug: Late surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late surfactant treatment (100 mg/kg body weight bovine surfactant)
Trial: 9794948
Drug: Early surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early surfactant treatment
Trial: 2615932
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of L-tryptophan
Trial: 208034
Drug: Quinestrol 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinestrol 0.2 mg once weekly
Trial: 208034
Drug: Quinestrol 0.1
RxNorm normalized name: quinestrol 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinestrol 0.1 mg once weekly
Trial: 208034
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens 1.25 mg daily for 21 days on and 7 days off
Trial: 30601336
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of tenofovir (TDF) and telbivudine (LdT)
Trial: 30601336
Drug: Tenofovir (TDF)
RxNorm normalized name: emtricitabine/tenofovir (TDF) 200 mg-300 mg ORAL TABLET
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir (TDF) single treatment
Trial: 27364375
Drug: Low calcium
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low calcium dialysate (1.3 mmol/L)
Trial: 27364375
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium dialysate (1.6 or 1.75 mmol/L)
Trial: 17689755
Drug: Lavender aromatherapy
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lavender aromatherapy (four drops of essential oil diluted with 20 ml of hot water and inhaled for 30 min)
Trial: 12497304
Drug: Fluoxetin (37
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetin (37 patients, dosage: 20-40 mg/day)
Trial: 12497304
Drug: Amitriptyline (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (40 patients, dosage: 25-75 mg/day)
Trial: 7540898
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (200 micrograms)
Trial: 7540898
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (800 micrograms)
Trial: 7540898
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (400 micrograms)
Trial: 1673953
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg daily (n = 54)
Trial: 1673953
Drug: H2 receptor
RxNorm normalized name: Histamine H2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2 receptor antagonist (n = 53)
Trial: 6269769
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus prophylactic whole brain radiation therapy
Trial: 24247554
Drug: GM‐CSF (leukine),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM‐CSF (leukine), 500 μg/day 3 times a week for 4 weeks
Trial: 11069440
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (once daily for 9 days)
Trial: 11069440
Drug: Intravenous amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amlodipine
Trial: 1591054
Drug: Formestane 250
RxNorm normalized name: formestane 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formestane 250 mg
Trial: 1591054
Drug: Formestane 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formestane 500 mg
Trial: 8507221
Drug: Leucovorin (2.5-5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucovorin (2.5-5.0 mg orally, given 24 hours after weekly methotrexate dose)
Trial: 8507221
Drug: Placebo (given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (given 24 hours after weekly methotrexate dose)
Trial: 28843819
Drug: Rifampicin-based systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin-based systemic antibiotics (oral rifampicin with clindamycin or trimethoprim/sulfamethoxazole for 7 days plus nasal mupirocin)
Trial: 28843819
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with mupirocin only
Trial: 25494594
Drug: Corn peptides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn peptides (CPs) 4 g/d for 9 weeks
Trial: 25494594
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (2 g twice daily)
Trial: 25494594
Drug: Corn starch
RxNorm normalized name: Corn Starch
DrugBank: Starch, corn (DB11599)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn starch placebo (2 g twice daily)
Trial: 22430300
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (50 U BT into the internal sphincter)
Trial: 20362857
Drug: Custom PRK
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Custom PRK (wavefront-guided custom treatment)
Trial: 15714983
Drug: Combined androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined androgen blockade using LHRH agonist and androgen antagonist
Trial: 15714983
Drug: Adjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant hormonal therapy (including intermittent hormonal therapy)
Trial: 12879653
Drug: Metformin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin with gonadotropins
Trial: 11051123
Drug: Sulthiame (STM)
RxNorm normalized name: Sulthiame
DrugBank: Sulthiame (DB08329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulthiame (STM) 5 mg/kg/day
Trial: 9006790
Drug: Peppermint oil
RxNorm normalized name: Peppermint Oil
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peppermint oil (90 mg) and caraway oil (50 mg) in an enteric coated capsule
Trial: 1587072
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg extended-release fenfluramine plus 15 mg phentermine resin
Trial: 3890395
Drug: Muzolimine (MZ)
RxNorm normalized name: Muzolimine
DrugBank: Muzolimine (DB13801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muzolimine (MZ) 20 mg/day
Trial: 3890395
Drug: Chlorthalidone (CL)
RxNorm normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (CL) 50 mg/day
Trial: 29419569
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg every day
Trial: 26689970
Drug: No detectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No detectable drug
Trial: 23321657
Drug: Daily vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vaginal estrogen cream for 2 to 12 weeks
Trial: 21406117
Drug: Continuous ultrasound
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ultrasound plus exercise therapy
Trial: 21406117
Drug: Placebo ultrasound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ultrasound plus exercise therapy
Trial: 20081257
Drug: Preoperative intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative intravenous tramadol (100 mg)
Trial: 17915641
Drug: Nimesulide in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide in tablets
Trial: 3122600
Drug: Naloxone infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone infusion (0.4 mg loading dose followed by 10 micrograms.kg‐1.hr‐1)
Trial: 3122600
Drug: Naloxone infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone infusion (0.2 mg loading dose followed by 5 micrograms.kg‐1.hr‐1)
Trial: 3122600
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (20 ml/hr)
Trial: 29307459
Drug: Non-ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ICD therapy
Trial: 28006855
Drug: Lenalidomide and
RxNorm normalized name: Lenalidomide
DrugBank: Lenalidomide (DB00480)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lenalidomide and low-dose dexamethasone (Rd)
Trial: 26223257
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg + ASA 100 mg
Trial: 26223257
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg + ASA 100 mg
Trial: 21173036
Drug: Heparin-coated CPB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated CPB (HC-group)
Trial: 12135019
Drug: Omeprazole with
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole with or without additional antibiotic therapy
Trial: 8620666
Drug: Zileuton 600mg
RxNorm normalized name: ZILEUTON 600MG TAB
DrugBank: Zileuton (DB00744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zileuton 600mg 4 times daily
Trial: 31944870
Drug: Accurate productions
RxNorm normalized name: Accutane Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accurate productions of real words (e.g., 'leaf')
Trial: 31944870
Drug: Misarticulated words
RxNorm normalized name: Wood creosote
DrugBank: Wood creosote (DB13271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misarticulated words (e.g., 'weaf' or 'yeaf')
Trial: 27710808
Drug: High-intensity statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity statin therapy (atorvastatin 80 mg or rosuvastatin 40 mg daily)
Trial: 19535099
Drug: Myofascial physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myofascial physical therapy
Trial: 20085491
Drug: Raltegravir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir (400 mg twice daily) plus optimized background therapy
Trial: 20085491
Drug: Optimized background
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimized background therapy alone
Trial: 19526756
Drug: Shengmai Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shengmai Injection (SMI)
Trial: 10543335
Drug: tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine 2 mg twice daily
Trial: 10543335
Drug: oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxybutynin 5 mg three times daily
Trial: 1938567
Drug: Radiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy combined with four heat treatments
Trial: 1938567
Drug: Radiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy combined with one heat treatment
Trial: 7278083
Drug: Cimetidine 10
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 10 mg intravenously
Trial: 7278083
Drug: Cimetidine high
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine high dose (not specified)
Trial: 25295663
Drug: Oral hydrogen-rich
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hydrogen-rich tablets (2 g per day)
Trial: 25295663
Drug: Oral hydrogen-rich
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hydrogen-rich tablets (2 g per day) and topical hydrogen-rich packs (6 times per day for 20 minutes)
Trial: 25295663
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional treatment protocol for soft tissue injury)
Trial: 19766645
Drug: PegIFNalpha2a plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PegIFNalpha2a plus RBV 800-1200 mg/day